News - Page 211

TLDR: Congolese logistics company Noki Noki secures $3 million in seed funding The funding will be used to expand operations and enter new markets A Congolese logistics firm, Noki Noki, has raised

TLDR: Amsterdam-based NLC Health Ventures and Alphabet’s healthtech company Verily have launched a new biotech startup called Exolvo Biosciences. Exolvo aims to improve drug delivery technology for biologic drugs, making treatments more

TLDR: Aquila, a wireless power startup, raised $2 million in funding led by Alua Group. The startup aims to develop optical power-beaming technology to charge drones wirelessly. Aquila, a deep tech startup

“`html TLDR: UBS is selling a partial stake in a securities joint venture to Beijing State-owned Asset Management (BSAM). The stake sale is part of UBS’s consolidation efforts in China after its

Zendesk creates global VC fund for investing in AI-first ventures TLDR: Zendesk has launched a global venture fund for AI-first companies called Zendesk Ventures They have already made investments in conversation AI

TLDR: Verituity, a US-based provider of verified payout solutions, has raised $18.8 million through a funding round led by Forgepoint Capital and Sandbox Industries. The funding will be used to expand into

Article Summary TLDR: HeyGen Raises US$60 Million in Funding HeyGen, an AI start-up, raised $60 million in its series A funding round led by Benchmark. The company, previously known as Surreal, rebranded

TLDR: Venture capitalists have profited from innovative ventures, but value hasn’t been shared with all stakeholders. A new model, the Happiness Return Framework, aims to assess investments based on well-being and financial

TLDR: Key points from the article: Gatreon Ventures has launched a $1 million Web3 fund to support innovative startups focused on Web3 technologies. The fund aims to empower founders by providing financial

TLDR: Leiden-based Vico Therapeutics secures €11.5M in funding from Seroba and Kurma Partners in a Series B financing round. The funding will help advance the development of therapies for severe neurological diseases.